MIRNA-Rx07

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMIRNA-Rx07
Drug Alias Namelet-7 miRNA mimetic (Asuragen)let-7 mimeticMiR-Rxlet-7 mimetic (Mirna)let-7 miRNA mimetic (Mirna)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale UniversityMirna Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A